Activity Overview
This educational activity is an archive
of the live conference held from January 23 to 25, 2026.
Target Audience
This educational activity is intended for oncologists involved in
the treatment and management of patients with lung cancer. Nurse practitioners,
nurses, physician assistants, pharmacists, clinical investigators, fellows, and
other health care professionals interested in the treatment of lung cancer may
also participate.
Learning Objectives
- Evaluate efficacy and safety data from recent clinical trials on established and emerging therapeutic approaches for lung cancer.
- Integrate the latest clinical evidence and guideline recommendations into the development of personalized treatment plans for patients with lung cancer
- Implement best practices to identify, prevent, and manage treatment-related adverse effects associated with novel therapies for lung cancer.
Julie R. Brahmer, MD, MSc, FASCO
Director, Thoracic Oncology Program
Kimmel Cancer Center at Johns Hopkins Bayview
Professor of Oncology
Johns Hopkins Kimmel Cancer Center
Baltimore, MD
Kathryn Arbour, MD
Thoracic Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, NY
Eric Singhi, MD
Assistant Professor
University of Texas MD Anderson Cancer Center
Houston, TX
Urs Weber, MD
Assistant Professor
University of Colorado Anschutz Medical Campus
Aurora, CO
Joshua Reuss, MD
Assistant Professor of Medicine
Georgetown University - Medical Center
Thoracic Medical Oncologist
MedStar Georgetown University
Washington, DC
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here